Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen Spotlight Gene Panels for Neurology and Endocrinology

Courtagen Life Sciences has launched 17 new gene panels in its Spotlight line of tests, expanding its menu in neurology, endocrinology, and other disease areas. The new tests include several pain-related panels, such as migraine, neuropathic pain, and abdominal pain. They also include endocrinology-related panels for hyper/hypoglycemia (MODY+), hyperparathyroidism, and pituitary hormone deficiency, and new neurology panels for neuromuscular disorders such as periodic paralysis, dystonia, and rhabdomyolysis.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.